Position in CYTK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$877,882
-$118,545 QoQ
Shares Held
10,305
-31.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#268
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. CYTK ranks #12 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $877,882 | 10,305 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $996,427 | 15,118 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $316,302 | 4,978 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $348,611 | 6,343 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $366,281 | 11,086 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $343,021 | 8,535 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $795,916 | 16,920 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $478,156 | 9,056 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $715,934 | 13,214 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $174,993 | 2,496 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,115,426 | 13,360 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $200,681 | 6,812 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $85,855 | 2,632 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $127,071 | 3,611 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $579,668 | 12,651 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $718,367 | 14,827 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $575,008 | 14,635 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $35,963 | 977 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $327,264 | 7,180 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $208,078 | 5,822 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $314,719 | 15,903 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $155,515 | 6,686 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $28,737 | 1,383 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $76,792 | 3,547 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $180,357 | 7,652 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,482 | 465 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||